Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia.
Saved in:
| Title: | Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. |
|---|---|
| Authors: | Azevedo RS; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Braish J; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gener-Ricos G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang G; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ohanian M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ishizawa J; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Swaminathan M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jan; Vol. 67 (1), pp. 220-224. Date of Electronic Publication: 2025 Oct 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2025.2568745 |
